Changing paradigms in sinus and skull base surgery as the COVID-19 pandemic evolves: Preliminary experience from a single Italian tertiary care center.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 11 05 2020
accepted: 18 05 2020
pubmed: 9 6 2020
medline: 21 7 2020
entrez: 9 6 2020
Statut: ppublish

Résumé

Italy was the first European country suffering from COVID-19. Health care resources were redirected to manage the pandemic. We present our initial experience with the management of urgent and nondeferrable surgeries for sinus and skull base diseases during the COVID-19 pandemic. A retrospective review of patients treated in a single referral center during the first 2 months of the pandemic was performed. A comparison between the last 2-month period and the same period of the previous year was carried out. Twenty-four patients fulfilled the inclusion criteria. A reduction of surgical activity was observed (-60.7%). A statistically significant difference in pathologies treated was found (P = .016), with malignancies being the most frequent indication for surgery (45.8%). Although we feel optimistic for the future, we do not feel it is already time to restart elective surgeries. Our experience may serve for other centers who are facing the same challenges.

Sections du résumé

BACKGROUND BACKGROUND
Italy was the first European country suffering from COVID-19. Health care resources were redirected to manage the pandemic. We present our initial experience with the management of urgent and nondeferrable surgeries for sinus and skull base diseases during the COVID-19 pandemic.
METHODS METHODS
A retrospective review of patients treated in a single referral center during the first 2 months of the pandemic was performed. A comparison between the last 2-month period and the same period of the previous year was carried out.
RESULTS RESULTS
Twenty-four patients fulfilled the inclusion criteria. A reduction of surgical activity was observed (-60.7%). A statistically significant difference in pathologies treated was found (P = .016), with malignancies being the most frequent indication for surgery (45.8%).
CONCLUSIONS CONCLUSIONS
Although we feel optimistic for the future, we do not feel it is already time to restart elective surgeries. Our experience may serve for other centers who are facing the same challenges.

Identifiants

pubmed: 32510716
doi: 10.1002/hed.26320
pmc: PMC7300474
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1610-1620

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

Int Forum Allergy Rhinol. 2020 Jul;10(7):798-805
pubmed: 32243678
JAMA. 2020 Mar 13;:
pubmed: 32167538
J Neurol Sci. 2020 May 15;412:116824
pubmed: 32299010
Neurosurgery. 2020 Aug 1;87(2):E160-E161
pubmed: 32302398
Head Neck. 2020 Jul;42(7):1503-1506
pubmed: 32415882
Head Neck. 2020 Jun;42(6):1125-1130
pubmed: 32342575
Neurosurgery. 2020 Aug 1;87(2):E162-E163
pubmed: 32323725
Head Neck. 2020 Jul;42(7):1674-1680
pubmed: 32374942
Rhinology. 2020 Jun 1;58(3):289-294
pubmed: 32441710
Otolaryngol Clin North Am. 2016 Feb;49(1):183-200
pubmed: 26614837
Neurosurgery. 2020 Jul 1;87(1):E66-E67
pubmed: 32293678
Head Neck. 2020 May;42(5):963-973
pubmed: 31889395
J Otolaryngol Head Neck Surg. 2020 May 6;49(1):28
pubmed: 32375884
JAMA Otolaryngol Head Neck Surg. 2020 Mar 20;:
pubmed: 32196070
Head Neck. 2020 Jul;42(7):1610-1620
pubmed: 32510716
Anesth Analg. 2020 Jul;131(1):37-42
pubmed: 32217947
Int Forum Allergy Rhinol. 2020 May;10(5):587-588
pubmed: 32297469
Rhinology. 2020 Feb 20;58(Suppl S29):1-464
pubmed: 32077450
Head Neck. 2020 Jul;42(7):1577-1582
pubmed: 32358853
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Laryngoscope. 2020 May 5;:
pubmed: 32369621
Int Forum Allergy Rhinol. 2020 Aug;10(8):963-967
pubmed: 32348025

Auteurs

Apostolos Karligkiotis (A)

Division of Otorhinolaryngology, Department of Surgical Specialties, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.

Alberto D Arosio (AD)

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria-Varese, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.

Paolo Battaglia (P)

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria-Varese, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
Head and Neck Surgery & Forensic Dissection Research center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.

Giorgio Sileo (G)

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria-Varese, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.

Camilla Czaczkes (C)

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria-Varese, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.

Luca Volpi (L)

Division of Otorhinolaryngology, Department of Surgical Specialties, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.

Mario Turri-Zanoni (M)

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria-Varese, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
Head and Neck Surgery & Forensic Dissection Research center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.

Paolo Castelnuovo (P)

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria-Varese, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
Head and Neck Surgery & Forensic Dissection Research center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH